Format
Sort by
Items per page

Send to

Choose Destination

Best matches for bone density AND estrogens AND fracture AND progestins:

Prevention and treatment of postmenopausal osteoporosis. Tella SH et al. J Steroid Biochem Mol Biol. (2014)

Steroidal contraceptives: effect on bone fractures in women. Lopez LM et al. Cochrane Database Syst Rev. (2014)

Estrogen and bone health in men and women. Cauley JA et al. Steroids. (2015)

Search results

Items: 1 to 20 of 64

1.

The safety and tolerability profile of therapies for the prevention and treatment of osteoporosis in postmenopausal women.

Komm BS, Morgenstern D, A Yamamoto L, Jenkins SN.

Expert Rev Clin Pharmacol. 2015;8(6):769-84. doi: 10.1586/17512433.2015.1099432. Epub 2015 Oct 20. Review.

PMID:
26482902
2.

Steroidal contraceptives: effect on bone fractures in women.

Lopez LM, Grimes DA, Schulz KF, Curtis KM, Chen M.

Cochrane Database Syst Rev. 2014 Jun 24;(6):CD006033. doi: 10.1002/14651858.CD006033.pub5. Review.

PMID:
24960023
3.

[Hormone replacement therapy in menopause].

Pardini D.

Arq Bras Endocrinol Metabol. 2014 Mar;58(2):172-81. Review. Portuguese.

4.

The Women's Health Initiative: Hormone Therapy and Calcium/Vitamin D supplementation trials.

Cauley JA.

Curr Osteoporos Rep. 2013 Sep;11(3):171-8. doi: 10.1007/s11914-013-0150-7. Review.

PMID:
23842639
5.

Update: estrogen and estrogen plus progestin therapy in the care of women at and after the menopause.

Davey DA.

Womens Health (Lond). 2012 Mar;8(2):169-89. doi: 10.2217/whe.12.1. Review.

PMID:
22375720
6.

Steroidal contraceptives: effect on bone fractures in women.

Lopez LM, Grimes DA, Schulz KF, Curtis KM.

Cochrane Database Syst Rev. 2011 Jul 6;(7):CD006033. doi: 10.1002/14651858.CD006033.pub4. Review. Update in: Cochrane Database Syst Rev. 2014;6:CD006033.

PMID:
21735401
7.

Effect of hormone therapy on lean body mass, falls, and fractures: 6-year results from the Women's Health Initiative hormone trials.

Bea JW, Zhao Q, Cauley JA, LaCroix AZ, Bassford T, Lewis CE, Jackson RD, Tylavsky FA, Chen Z.

Menopause. 2011 Jan;18(1):44-52. doi: 10.1097/gme.0b013e3181e3aab1.

8.

The effects of hormonal contraceptives on bone turnover markers and bone health.

Herrmann M, Seibel MJ.

Clin Endocrinol (Oxf). 2010 May;72(5):571-83. doi: 10.1111/j.1365-2265.2009.03688.x. Epub 2009 Sep 9. Review.

PMID:
19740118
9.

Trends and determinants of prescription medication use for treatment of osteoporosis.

Farley JF, Blalock SJ.

Am J Health Syst Pharm. 2009 Jul 1;66(13):1191-201. doi: 10.2146/ajhp080248.

PMID:
19535658
10.

Steroidal contraceptives: effect on bone fractures in women.

Lopez LM, Grimes DA, Schulz KF, Curtis KM.

Cochrane Database Syst Rev. 2009 Apr 15;(2):CD006033. doi: 10.1002/14651858.CD006033.pub3. Review. Update in: Cochrane Database Syst Rev. 2011;(7):CD006033.

PMID:
19370623
11.

Bone mineral density and sex hormone status in intellectually disabled women on progestin-induced amenorrhea.

Arvio M, Kilpinen-Loisa P, Tiitinen A, Huovinen K, Mäkitie O.

Acta Obstet Gynecol Scand. 2009;88(4):428-33. doi: 10.1080/00016340902763244.

PMID:
19330573
12.

Effects of ovariectomy on bone turnover, porosity, and biomechanical properties in ovine compact bone 12 months postsurgery.

Kennedy OD, Brennan O, Rackard SM, Staines A, O'Brien FJ, Taylor D, Lee TC.

J Orthop Res. 2009 Mar;27(3):303-9. doi: 10.1002/jor.20750.

13.

[Update on the progestin-only contraception].

Madelenat P, Koskas M; Groupe de réflexion sur la contraception progestative.

J Gynecol Obstet Biol Reprod (Paris). 2008 Nov;37(7):637-60. doi: 10.1016/j.jgyn.2008.06.013. Epub 2008 Sep 27. French.

14.

Hormone therapy improves femur geometry among ethnically diverse postmenopausal participants in the Women's Health Initiative hormone intervention trials.

Chen Z, Beck TJ, Cauley JA, Lewis CE, LaCroix A, Bassford T, Wu G, Sherrill D, Going S.

J Bone Miner Res. 2008 Dec;23(12):1935-45. doi: 10.1359/jbmr.080707.

15.

Parathyroid hormone(1-84) treatment of postmenopausal women with low bone mass receiving hormone replacement therapy.

Fogelman I, Fordham JN, Fraser WD, Spector TD, Christiansen C, Morris SA, Fox J.

Calcif Tissue Int. 2008 Aug;83(2):85-92. doi: 10.1007/s00223-008-9152-3. Epub 2008 Jul 15.

PMID:
18626566
16.

Long-term effects of progestins on bone quality and fractures.

Thijssen JH.

Gynecol Endocrinol. 2007 Oct;23 Suppl 1:45-52. Review.

PMID:
17943539
17.

Steroidal contraceptives: effect on bone fractures in women.

Lopez LM, Grimes DA, Schulz KF, Curtis KM.

Cochrane Database Syst Rev. 2006 Oct 18;(4):CD006033. Review. Update in: Cochrane Database Syst Rev. 2009;(2):CD006033.

PMID:
17054270
18.

Benefits and risks of long-term low-dose oral continuous combined hormone therapy.

van de Weijer PH, Mattsson LA, Ylikorkala O.

Maturitas. 2007 Mar 20;56(3):231-48. Epub 2006 Oct 10. Review.

PMID:
17034966
19.

[Hormone replacement therapy in the management of postmenopausal osteoporosis and prevention of fracture risk].

Ribot C, Trémollières F.

Presse Med. 2006 Oct;35(10 Pt 2):1557-63. Review. French.

PMID:
17028521
20.

Low-dose estrogen therapy for prevention of osteoporosis: working our way back to monotherapy.

Richman S, Edusa V, Fadiel A, Naftolin F.

Menopause. 2006 Jan-Feb;13(1):148-55.

PMID:
16607111

Supplemental Content

Loading ...
Support Center